SCHEMBL12601151

SCHEMBL12601151

CCN1Cc2ccncc2S1(=O)=O

nearest known ligand 0.34

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
CACNA1H O95180 3/20 0.34
KEAP1 Q14145 2/20 0.33
NFE2L2 Q16236 2/20 0.33
KCNH2 Q12809 2/20 0.33
NAMPT P43490 6/20 0.33
CYP3A4 P08684 2/20 0.33
CYP2E1 P05181 1/20 0.33
CYP2A6 P11509 1/20 0.33
CYP2C9 P11712 1/20 0.33
CYP2B6 P20813 1/20 0.33
CYP2C19 P33261 1/20 0.33
PER2 O15055 1/20 0.32
CRY1 Q16526 1/20 0.32
CRY2 Q49AN0 1/20 0.32
SIGMAR1 Q99720 1/20 0.32
FFAR4 Q5NUL3 2/20 0.31
PDE3B Q13370 1/20 0.31
PDE3A Q14432 1/20 0.31
HRH4 Q9H3N8 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13632830 0.87 CACNA1H (0.34) CACNA1HKCNH2NAMPTCYP3A4CYP2E1
SCHEMBL8283891 0.83 ATM (0.44) CACNA1HKCNH2NAMPTCYP3A4PER2
SCHEMBL10278293 0.76 PER2 (0.50) CACNA1HKCNH2PER2CRY1CRY2
SCHEMBL9261326 0.74 FFAR4 (0.33) CACNA1HKCNH2NAMPTCYP3A4CYP2C9
SCHEMBL17310434 0.71 PER2 (0.32) CACNA1HKCNH2PER2CRY1CRY2
SCHEMBL8283895 0.71 ATM (0.44) CACNA1HKCNH2NAMPTCYP3A4PER2
SCHEMBL20283054 0.70 KEAP1 (0.44) KEAP1NFE2L2
SCHEMBL12600963 0.69 GRIA2 (0.39) CACNA1HCYP3A4CYP2E1CYP2A6CYP2C9
SCHEMBL16098296 0.68 ATM (0.47) CACNA1HKCNH2PER2CRY1CRY2
SCHEMBL8199408 0.68 GRIA2 (0.44) CACNA1HKCNH2CYP3A4CYP2E1CYP2A6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1730142-B1 NOVEL KETOAMIDES WITH CYCLIC P4'S AS INHIBITORS OF NS3 SERINE PROTEASE OF HEPATITIS C VIRUS SCHERING CORP (US) 2011-06-29 EP disclosed